Description

Moxifloxacin Hydrochloride

Moxifloxacin Hydrochloride is a high-purity Fluoroquinolone antibacterial agent used in the formulation of pharmaceutical products targeting respiratory, ocular, and dermal infections. Moxifloxacin

• Is a USP-grade active pharmaceutical ingredient (API)
• Has broad-spectrum efficacy against Gram-positive and Gram-negative bacteria
• Is suitable for oral, ophthalmic, and topical formulations
• Features high solubility and chemical stability across formulation conditions
• Is manufactured under cGMP
• Is available with full regulatory documentation

Moxifloxacin Hydrochloride is widely used in pharmaceutical development due to its robust antimicrobial spectrum and versatile formulation compatibility. As a fourth-generation Fuoroquinolone, it exerts its antibacterial effect by inhibiting DNA gyrase and topoisomerase IV—enzymes essential for bacterial DNA replication. Its broad-spectrum activity includes key pathogens such as Streptococcus pneumoniae, Haemophilus influenzae, and Staphylococcus aureus.

This API is used in the formulation of oral tablets, ophthalmic solutions, and topical anti-infective preparations, particularly in treatments for bacterial sinusitis, bronchitis, conjunctivitis, and skin infections. Its well-characterized pharmacokinetic and safety profile supports regulatory acceptance and ease of integration into both generic and branded therapeutic products.

CarboMer supplies Moxifloxacin Hydrochloride in bulk quantities, meeting stringent quality standards for pharmaceutical applications. Clients looking to purchase Moxifloxacin Hydrochloride benefit from consistent batch reproducibility, secure packaging, and global documentation support. Regulatory professionals and formulation scientists can access technical files to facilitate rapid integration and submission readiness.

The product is available in tamper-evident containers suitable for research, pilot, and commercial-scale production.

Every product batch is tested for identity, potency, purity, and microbiological safety to meet or exceed USP standards. Manufacturing is supported by validated processes, full traceability, and product quality monitoring.

As with all CarboMer APIs, Moxifloxacin Hydrochloride is supported by a comprehensive suite of services including formulation guidance, technical consulting, and regulatory documentation—ensuring dependable performance across the pharmaceutical development lifecycle.